Oslo, August 20[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the second quarter and first half-year of 2021, reporting continuous progress in the go-to-market execution for Sippi®, a unique and proprietary solution for digital, automated urine monitoring. “We have a sharp focus on continuous roll-out of Sippi®,…Read more
Medtech that matters
As healthcare challenges continue to grow, so does the need for innovative ways to meet them. Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively.
Read our latest news
Observe Medical ASA invites you to a presentation of the second quarter and first half year 2021. The presentation will take place at Felix Konferansesenter in Oslo on Friday, August 20th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_3/ …Read more
Observe Medical continues the roll-out of Sippi® – signs distribution agreement for launch in Poland and Romania
Oslo June 30, 2021 – Observe Medical ASA (OSE: OBSRV), today announces that it has entered into a distribution agreement and partnership with Skamex (Poland) for the launch of Sippi® in the Polish and the Romanian market. “We are pleased to announce that we are taking additional steps in the roll-out of Sippi® through our…Read more
Nordic solutions to global challenges
Observe Medical is a Nordic based medtech developer with development, quality, regulatory and commercial operations in Gothenburg, Sweden, and headquarters in Oslo, Norway.
Innovation for healthcare needs
The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi infection inhibiting automated digital urine meter system from Observe Medical can help.